Nanomaterials and Nanostructures Hand-In-Hand with Biology.

The nanoparticle's synthesis had its tipping point at the beginning of the 21st century, opening up the possibility of manufacturing nanoparticles with almost every imaginable shape and size [...

Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@AgS and PLGA@AgS@SPION Nanocarriers with Drug Release Capability.

AgS nanoparticles are near-infrared (NIR) probes providing emission in a specific spectral range (~1200 nm), and superparamagnetic iron oxide nanoparticles (SPION) are colloidal systems able to respond to an external magnetic field. A disadvantage of AgS NPs is the attenuated luminescent properties are reduced in aqueous media and human fluids. Concerning SPION, the main drawback is the generation of undesirable clusters that reduce particle stability.

10-Fold Quantum Yield Improvement of AgS Nanoparticles by Fine Compositional Tuning.

AgS semiconductor nanoparticles (NPs) are near-infrared luminescent probes with outstanding properties (good biocompatibility, optimum spectral operation range, and easy biofunctionalization) that make them ideal probes for in vivo imaging. AgS NPs have, indeed, made possible amazing challenges including in vivo brain imaging and advanced diagnosis of the cardiovascular system. Despite the continuous redesign of synthesis routes, the emission quantum yield (QY) of AgS NPs is typically below 0.

Nanoparticles for multimodal antivascular therapeutics: Dual drug release, photothermal and photodynamic therapy.

The poor delivery of nanoparticles to target cancer cells hinders their success in the clinical setting. In this work, an alternative target readily available for circulating nanoparticles has been selected to eliminate the need for nanoparticle penetration in the tissue: the tumor blood vessels. A tumor endothelium-targeted nanoparticle (employing an RGD-containing peptide) capable of co-delivering two anti-vascular drugs (one anti-angiogenic drug and one vascular disruption agent) is here presented.